Tradestie Institutional Equity Comparison Engine
AHCO vs BBNX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AHCO Overall Edge
AHCO Captures Institutional Edge (4โ0 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AdaptHealth Corp. Common Stock (AHCO) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AHCO trades at 7.8x Forward P/E with 3.8% operating margin (+10.9% YoY revenue) versus BBNX at N/M Forward P/E and -72.8% operating margin (+30.3% YoY). In options structure, AHCO sits in SURGE (12th %ile IV; Dealer Gamma Walls on Pro) against BBNX sits in CONSOLIDATION (<1st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
AHCO
AHCO 7.8x vs BBNX N/M Fwd P/E
Growth & Margin Winner
AHCO
Op Margin 3.8% vs -72.8% ยท YoY +10.9% vs +30.3%
Momentum & Technical Winner
AHCO
1Y -20.9% vs -51.8% ยท 52W Pos 24% vs 19%
Options & Structure Winner
AHCO
SURGE (12th %ile IV) vs CONSOLIDATION (<1st %ile IV)
AHCO
NASDAQ
AdaptHealth Corp. Common Stock
Services-Home Health Care Services
$7.20
-0.69% 1D
Market Cap
$989.8M
1M Return
+16.69%
1Y Return
-20.88%
Forward P/E
7.8x
Unified AI Score
45.2 / 100
HOLD
Tech 29.0
Fund 46.0
Flow 54.0
Mom 60.0
BBNX
NASDAQ
Beta Bionics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$13.36
+0.3% 1D
Market Cap
$724.2M
1M Return
-30.92%
1Y Return
-51.8%
Forward P/E
N/M
Unified AI Score
52.1 / 100
HOLD
Tech 50.0
Fund 53.0
Flow 69.0
Mom 68.9
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AHCO -20.88%
BBNX -51.8%
Spread: +30.92 pp (AHCO Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | AHCO Revenue | BBNX Revenue | AHCO Op. Margin | BBNX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $350M | N/A | 9.0% | N/A | AHCO |
| FY2019 | $530M | N/A | 5.5% | N/A | AHCO |
| FY2020 | $1.06B | N/A | 6.8% | N/A | AHCO |
| FY2021 | $2.45B | N/A | 9.2% | N/A | AHCO |
| FY2022 | $2.97B | N/A | 6.4% | N/A | AHCO |
| FY2023 | $3.20B | $10M | -18.7% | -298.9% | AHCO |
| FY2024 | $3.26B | $70M | 8.1% | -69.5% | AHCO |
| FY2025 | $3.24B | $100M | 2.8% | -71.5% | AHCO |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AHCO | BBNX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $989.8M | $724.2M | Larger Scale | AHCO |
| Trailing P/E Ratio Valuation | 7.8x | N/M | Lower Multiple | AHCO |
| Forward P/E Ratio Valuation | 7.8x | N/M | Lower Multiple | AHCO |
| Revenue Growth (YoY) Growth | +10.9% | +30.3% | Higher Growth | BBNX |
| Operating Margin (TTM) Profitability | 3.8% | -72.8% | Higher Margin | AHCO |
| Net Profit Margin Profitability | -11.8% | -65.3% | Higher Margin | AHCO |
| Return on Equity (ROE) Capital Efficiency | -28.4% | -23.9% | Higher ROE | BBNX |
| 52-Week Range Position Momentum | 24% ($5โ$13) | 19% ($9โ$33) | Stronger Trend | AHCO |
| Beta / 30D Volatility Risk Regime | 0.17ฮฒ ยท 67% Vol | 1.75ฮฒ ยท 104% Vol | Lower Realized Risk | AHCO |
| Unified Institutional Score Composite Signal | 45.2 / 100 (HOLD) | 52.1 / 100 (HOLD) | Higher Composite | BBNX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AHCO vs BBNX Buy Guide
AHCO
SURGE
6d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
12th %ile
IV Regime
Compressed (<25th %ile)
BBNX
CONSOLIDATION
88d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AHCO nor BBNX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.